nodes	percent_of_prediction	percent_of_DWPC	metapath
Perflutren—Sevoflurane—ALB—chronic obstructive pulmonary disease	0.00642	1	CrCbGaD
Perflutren—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.00161	CcSEcCtD
Perflutren—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00161	CcSEcCtD
Perflutren—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00161	CcSEcCtD
Perflutren—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00161	CcSEcCtD
Perflutren—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00161	CcSEcCtD
Perflutren—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00161	CcSEcCtD
Perflutren—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00161	CcSEcCtD
Perflutren—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00161	CcSEcCtD
Perflutren—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00161	CcSEcCtD
Perflutren—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.00161	CcSEcCtD
Perflutren—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.0016	CcSEcCtD
Perflutren—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.0016	CcSEcCtD
Perflutren—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00159	0.0016	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00159	0.0016	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.0016	CcSEcCtD
Perflutren—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00158	0.00159	CcSEcCtD
Perflutren—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00158	0.00159	CcSEcCtD
Perflutren—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00157	0.00158	CcSEcCtD
Perflutren—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00158	CcSEcCtD
Perflutren—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00157	0.00158	CcSEcCtD
Perflutren—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00158	CcSEcCtD
Perflutren—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00158	CcSEcCtD
Perflutren—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00157	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00157	CcSEcCtD
Perflutren—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00155	0.00156	CcSEcCtD
Perflutren—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00155	0.00156	CcSEcCtD
Perflutren—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00156	CcSEcCtD
Perflutren—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00154	CcSEcCtD
Perflutren—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00154	CcSEcCtD
Perflutren—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00153	0.00154	CcSEcCtD
Perflutren—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00153	0.00154	CcSEcCtD
Perflutren—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00154	CcSEcCtD
Perflutren—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00152	CcSEcCtD
Perflutren—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00152	CcSEcCtD
Perflutren—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00152	CcSEcCtD
Perflutren—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.00152	CcSEcCtD
Perflutren—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00151	CcSEcCtD
Perflutren—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00151	CcSEcCtD
Perflutren—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.0015	0.00151	CcSEcCtD
Perflutren—Oedema—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00151	CcSEcCtD
Perflutren—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.0015	0.00151	CcSEcCtD
Perflutren—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00151	CcSEcCtD
Perflutren—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00151	CcSEcCtD
Perflutren—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00149	0.0015	CcSEcCtD
Perflutren—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00149	0.0015	CcSEcCtD
Perflutren—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.0015	CcSEcCtD
Perflutren—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00149	0.00149	CcSEcCtD
Perflutren—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00149	CcSEcCtD
Perflutren—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00148	CcSEcCtD
Perflutren—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00147	CcSEcCtD
Perflutren—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00146	CcSEcCtD
Perflutren—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00146	CcSEcCtD
Perflutren—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00144	CcSEcCtD
Perflutren—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00144	CcSEcCtD
Perflutren—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00143	0.00144	CcSEcCtD
Perflutren—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00143	CcSEcCtD
Perflutren—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00142	0.00143	CcSEcCtD
Perflutren—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00143	CcSEcCtD
Perflutren—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00142	CcSEcCtD
Perflutren—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00142	CcSEcCtD
Perflutren—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.0014	0.00141	CcSEcCtD
Perflutren—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00141	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00141	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00141	CcSEcCtD
Perflutren—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00139	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00138	CcSEcCtD
Perflutren—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00138	CcSEcCtD
Perflutren—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00138	CcSEcCtD
Perflutren—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00136	CcSEcCtD
Perflutren—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00136	CcSEcCtD
Perflutren—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00136	CcSEcCtD
Perflutren—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00136	CcSEcCtD
Perflutren—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00135	0.00136	CcSEcCtD
Perflutren—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Perflutren—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00133	0.00134	CcSEcCtD
Perflutren—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00133	CcSEcCtD
Perflutren—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00133	CcSEcCtD
Perflutren—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00133	CcSEcCtD
Perflutren—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00132	0.00133	CcSEcCtD
Perflutren—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.00133	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00133	CcSEcCtD
Perflutren—Pain—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00132	CcSEcCtD
Perflutren—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00132	CcSEcCtD
Perflutren—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00131	CcSEcCtD
Perflutren—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.0013	0.00131	CcSEcCtD
Perflutren—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.0013	0.0013	CcSEcCtD
Perflutren—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.0013	CcSEcCtD
Perflutren—Pain—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00129	CcSEcCtD
Perflutren—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00128	0.00129	CcSEcCtD
Perflutren—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00128	0.00129	CcSEcCtD
Perflutren—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00128	CcSEcCtD
Perflutren—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00128	CcSEcCtD
Perflutren—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00127	0.00128	CcSEcCtD
Perflutren—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00127	0.00127	CcSEcCtD
Perflutren—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00127	CcSEcCtD
Perflutren—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00127	CcSEcCtD
Perflutren—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00127	CcSEcCtD
Perflutren—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00127	CcSEcCtD
Perflutren—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00125	0.00126	CcSEcCtD
Perflutren—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00125	0.00126	CcSEcCtD
Perflutren—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00126	CcSEcCtD
Perflutren—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00126	CcSEcCtD
Perflutren—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00125	CcSEcCtD
Perflutren—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00124	CcSEcCtD
Perflutren—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00123	CcSEcCtD
Perflutren—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00123	CcSEcCtD
Perflutren—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00122	CcSEcCtD
Perflutren—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00122	CcSEcCtD
Perflutren—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00121	0.00122	CcSEcCtD
Perflutren—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00121	0.00122	CcSEcCtD
Perflutren—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00121	0.00122	CcSEcCtD
Perflutren—Rash—Tiotropium—chronic obstructive pulmonary disease	0.0012	0.00121	CcSEcCtD
Perflutren—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.0012	0.00121	CcSEcCtD
Perflutren—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00121	CcSEcCtD
Perflutren—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00119	0.0012	CcSEcCtD
Perflutren—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.0012	CcSEcCtD
Perflutren—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00119	0.0012	CcSEcCtD
Perflutren—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.0012	CcSEcCtD
Perflutren—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00119	0.0012	CcSEcCtD
Perflutren—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00119	0.0012	CcSEcCtD
Perflutren—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.00119	0.00119	CcSEcCtD
Perflutren—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00119	CcSEcCtD
Perflutren—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Perflutren—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00118	CcSEcCtD
Perflutren—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00118	CcSEcCtD
Perflutren—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00116	CcSEcCtD
Perflutren—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Perflutren—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00115	CcSEcCtD
Perflutren—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00114	CcSEcCtD
Perflutren—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00114	CcSEcCtD
Perflutren—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00114	CcSEcCtD
Perflutren—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Perflutren—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00113	CcSEcCtD
Perflutren—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Perflutren—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00111	CcSEcCtD
Perflutren—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00111	CcSEcCtD
Perflutren—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Perflutren—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00109	0.00109	CcSEcCtD
Perflutren—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00109	CcSEcCtD
Perflutren—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Perflutren—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00106	0.00107	CcSEcCtD
Perflutren—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00106	CcSEcCtD
Perflutren—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00106	CcSEcCtD
Perflutren—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.00104	0.00105	CcSEcCtD
Perflutren—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00105	CcSEcCtD
Perflutren—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.00103	0.00104	CcSEcCtD
Perflutren—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Perflutren—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00103	0.00103	CcSEcCtD
Perflutren—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00102	CcSEcCtD
Perflutren—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Perflutren—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00102	CcSEcCtD
Perflutren—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000994	0.001	CcSEcCtD
Perflutren—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000991	0.000998	CcSEcCtD
Perflutren—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000976	0.000982	CcSEcCtD
Perflutren—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000976	0.000982	CcSEcCtD
Perflutren—Rash—Formoterol—chronic obstructive pulmonary disease	0.000967	0.000974	CcSEcCtD
Perflutren—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000967	0.000974	CcSEcCtD
Perflutren—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000967	0.000973	CcSEcCtD
Perflutren—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000967	0.000973	CcSEcCtD
Perflutren—Headache—Formoterol—chronic obstructive pulmonary disease	0.000961	0.000967	CcSEcCtD
Perflutren—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000961	0.000967	CcSEcCtD
Perflutren—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00096	0.000966	CcSEcCtD
Perflutren—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000958	0.000964	CcSEcCtD
Perflutren—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000956	0.000962	CcSEcCtD
Perflutren—Rash—Montelukast—chronic obstructive pulmonary disease	0.000948	0.000954	CcSEcCtD
Perflutren—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000947	0.000953	CcSEcCtD
Perflutren—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000945	0.000951	CcSEcCtD
Perflutren—Headache—Montelukast—chronic obstructive pulmonary disease	0.000941	0.000948	CcSEcCtD
Perflutren—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00093	0.000936	CcSEcCtD
Perflutren—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000928	0.000934	CcSEcCtD
Perflutren—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000921	0.000927	CcSEcCtD
Perflutren—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000918	0.000924	CcSEcCtD
Perflutren—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000915	0.000921	CcSEcCtD
Perflutren—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000913	0.000919	CcSEcCtD
Perflutren—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000913	0.000919	CcSEcCtD
Perflutren—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000913	0.000919	CcSEcCtD
Perflutren—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000911	0.000917	CcSEcCtD
Perflutren—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000911	0.000917	CcSEcCtD
Perflutren—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000908	0.000913	CcSEcCtD
Perflutren—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000895	0.000901	CcSEcCtD
Perflutren—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000893	0.000898	CcSEcCtD
Perflutren—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000882	0.000888	CcSEcCtD
Perflutren—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000879	0.000885	CcSEcCtD
Perflutren—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000865	0.000871	CcSEcCtD
Perflutren—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000861	0.000866	CcSEcCtD
Perflutren—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000856	0.000862	CcSEcCtD
Perflutren—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000854	0.00086	CcSEcCtD
Perflutren—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00085	0.000855	CcSEcCtD
Perflutren—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000835	0.000841	CcSEcCtD
Perflutren—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000831	0.000836	CcSEcCtD
Perflutren—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000831	0.000836	CcSEcCtD
Perflutren—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000818	0.000823	CcSEcCtD
Perflutren—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000811	0.000816	CcSEcCtD
Perflutren—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000803	0.000808	CcSEcCtD
Perflutren—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000794	0.000799	CcSEcCtD
Perflutren—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000789	0.000794	CcSEcCtD
Perflutren—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000771	0.000776	CcSEcCtD
Perflutren—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000768	0.000773	CcSEcCtD
Perflutren—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000759	0.000764	CcSEcCtD
Perflutren—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000746	0.000751	CcSEcCtD
Perflutren—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00074	0.000745	CcSEcCtD
Perflutren—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000711	0.000715	CcSEcCtD
Perflutren—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000697	0.000702	CcSEcCtD
Perflutren—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000686	0.000691	CcSEcCtD
Perflutren—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000685	0.000689	CcSEcCtD
Perflutren—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00068	0.000684	CcSEcCtD
Perflutren—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000676	0.00068	CcSEcCtD
Perflutren—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000667	0.000672	CcSEcCtD
Perflutren—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000665	0.000669	CcSEcCtD
Perflutren—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000663	0.000668	CcSEcCtD
Perflutren—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00066	0.000664	CcSEcCtD
Perflutren—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00065	0.000654	CcSEcCtD
Perflutren—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000641	0.000645	CcSEcCtD
Perflutren—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000639	0.000643	CcSEcCtD
Perflutren—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00063	0.000634	CcSEcCtD
Perflutren—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00063	0.000634	CcSEcCtD
Perflutren—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000626	0.00063	CcSEcCtD
Perflutren—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000622	0.000626	CcSEcCtD
Perflutren—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000612	0.000616	CcSEcCtD
Perflutren—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000604	0.000608	CcSEcCtD
Perflutren—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000604	0.000608	CcSEcCtD
Perflutren—Shock—Prednisone—chronic obstructive pulmonary disease	0.000594	0.000598	CcSEcCtD
Perflutren—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000592	0.000596	CcSEcCtD
Perflutren—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000589	0.000593	CcSEcCtD
Perflutren—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000587	0.00059	CcSEcCtD
Perflutren—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000584	0.000588	CcSEcCtD
Perflutren—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.00055	0.000554	CcSEcCtD
Perflutren—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000549	0.000553	CcSEcCtD
Perflutren—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000542	0.000546	CcSEcCtD
Perflutren—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000532	0.000535	CcSEcCtD
Perflutren—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000524	0.000527	CcSEcCtD
Perflutren—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000523	0.000527	CcSEcCtD
Perflutren—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000521	0.000524	CcSEcCtD
Perflutren—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000521	0.000524	CcSEcCtD
Perflutren—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000498	0.000501	CcSEcCtD
Perflutren—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000494	0.000497	CcSEcCtD
Perflutren—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000494	0.000497	CcSEcCtD
Perflutren—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00048	0.000483	CcSEcCtD
Perflutren—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00048	CcSEcCtD
Perflutren—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000477	0.00048	CcSEcCtD
Perflutren—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000445	0.000448	CcSEcCtD
Perflutren—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000433	0.000436	CcSEcCtD
Perflutren—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000427	0.00043	CcSEcCtD
Perflutren—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000413	0.000416	CcSEcCtD
Perflutren—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000399	0.000402	CcSEcCtD
Perflutren—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000384	0.000386	CcSEcCtD
Perflutren—Rash—Prednisone—chronic obstructive pulmonary disease	0.000381	0.000383	CcSEcCtD
Perflutren—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.00038	0.000383	CcSEcCtD
Perflutren—Headache—Prednisone—chronic obstructive pulmonary disease	0.000378	0.000381	CcSEcCtD
Perflutren—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000359	0.000361	CcSEcCtD
